12:00 AM
Jan 09, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CN54gp140 HIV vaccine: Phase I started

Investigators from the universities, the Medical Research Council clinical trial unit and IDRI began the U.K. Phase I MUCOVAC2 trial of CN54gp140 in 36 healthy women volunteers ages 18-45 years. The subjects will receive the...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >